Ignite Creation Date:
2025-12-25 @ 2:26 AM
Ignite Modification Date:
2025-12-27 @ 10:58 PM
Study NCT ID:
NCT00906334
Status:
COMPLETED
Last Update Posted:
2017-06-26
First Post:
2009-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Classified as Intermediate-1, -2 or High Risk
Sponsor:
Traws Pharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-05
Start Date Type:
None
Primary Completion Date:
2013-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-11
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-19
First Submit QC Date:
None
Study First Post Date:
2009-05-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-05-05
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-06-22
Last Update Post Date:
2017-06-26
Last Update Post Date Type:
ACTUAL